JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, cilt.95, sa.4, ss.1972-1980, 2010 (SCI-Expanded)
Context: Tetraiodothyroacetic acid (tetrac) blocks angiogenic and tumor cell proliferation actions of thyroid hormone initiated at the cell surface hormone receptor on integrin alpha v beta 3. Tetrac also inhibits angiogenesis initiated by vascular endothelial growth factor and basic fibroblast growth factor.